Audrey Leishman, a Virginia Beach mother, survived a severe sepsis scare and now advocates for awareness through her Begin ...

The Supreme Court on Thursday set aside the “status quo ante bellum” order made in the leadership crisis rocking the African Democratic Congress, ruling that the preservative directive could not ...

Figure 1 depicts the ways in which implicit bias (including stereotypes) that leads to false assumptions about an individual patient, combined with inattention to systemic and structural factors ...

KENT, Wash. — A world-renowned nursery that has cared for babies born withdrawing from drugs like opioids discharged its last patient Monday. This comes after the Department of Children, Youth and ...

KENT, Wash. — A longtime resource to help drug-exposed newborns said it was blindsided by Washington state and was told it has to shut down at the end of the month. The founder of the Pediatric ...

The pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its potential for harsh side effects. There is still more work to be done to refine ...

Antibody-drug conjugates (ADCs) are a growing class of biotherapeutics that have transformed targeted therapy, especially in oncology. By making use of monoclonal antibodies’ specificity to deliver ...

As a creative individual, Jordan Tassiello has a track record of achievements in founding her own business and working with large companies on writing, editing, design, content creation and campaigns.

New catheter materials for peripherally inserted central catheters (PICCs) may reduce the risk of device failure due to infectious, thrombotic, and catheter occlusion events. However, data from ...

Merck & Co. has shown off data on its ROR1-directed antibody-drug conjugate (ADC), trumpeting a 100% complete response rate but also reporting safety signals that informed the decision to take the low ...

ADC Therapeutics, Sutro Biopharma and Zai Lab are among those developing antibody-drug conjugates to address payload and toxicity challenges of current ADCs—and rapidly grow the multibillion-dollar ...